More From The Market Online
FDA approval not enough to revive local Telix Pharma bulls as stock pulls back again
While it’s generally a true maxim that for ASX-listed healthcare companies US FDA approvals tend to be a major upside catalyst, this week
- Jonathon Davidson
- 2 mins
- 16 September 2026 10:45 (AEST)
Argenica Therapeutics’ concussion data selected for international neurotrauma congress
Argenica Therapeutics' recent preclinical concussion study has been selected for oral presentation at an international meeting…
- Colin Sandell-Hay
- 2 mins
- 15 September 2026 14:20 (AEST)
Prescient Therapeutics nears a pivotal moment as PTX-100 Phase 2a trial hits key milestone
As cancer rates around the world climb for a range of reasons, one of the most active frontiers in the oncology space remains
- Jonathon Davidson
- 5 mins
- 16 September 2026 07:00 (AEST)
QEM targets new US critical minerals opportunities with Big It and Garden Valley
QEM is building a new US critical minerals portfolio around its Big It tungsten project and…
- Seja Al Zaidi
- 2 mins
- 15 September 2026 11:54 (AEST)
